Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Loren Mell

    TitleTeacher
    SchoolUniversity of California, San Diego
    Address9500 Gilman Drive #0861
    CA La Jolla 92093
    Phone858-246-0471
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Effectiveness of IG-IMRT for Locally Advanced Cervix Cancer on NRG Trial CVM-1421
      NIH/NCI R01CA197059Jul 2, 2015 - Jun 30, 2018
      Role: Principal Investigator
      Image-guided bone marrow-sparing IMRT for cervical cancer
      NIH/NCI R21CA162718Sep 12, 2011 - Aug 31, 2014
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Mell L, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA. Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma. Clin Cancer Res. 2017 Jul 05. PMID: 28679776.
        View in: PubMed
      2. Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell L, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 Jun; 15(6):761-770. PMID: 28596256.
        View in: PubMed
      3. Li N, Noticewala SS, Williamson CW, Shen H, Sirak I, Tarnawski R, Mahantshetty U, Hoh CK, Moore KL, Mell L. Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer. Radiother Oncol. 2017 May; 123(2):325-330. PMID: 28528206.
        View in: PubMed
      4. Bryant AK, Banegas MP, Martinez ME, Mell L, Murphy JD. Trends in Radiation Therapy among Cancer Survivors in the United States, 2000-2030. Cancer Epidemiol Biomarkers Prev. 2017 Jun; 26(6):963-970. PMID: 28096199.
        View in: PubMed
      5. Noticewala SS, Li N, Williamson CW, Hoh CK, Shen H, McHale MT, Saenz CC, Einck J, Plaxe S, Vaida F, Yashar CM, Mell L. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Mar 15; 97(4):797-805. PMID: 28244416.
        View in: PubMed
      6. Mell L, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2). Int J Radiat Oncol Biol Phys. 2017 Mar 01; 97(3):536-545. PMID: 28126303.
        View in: PubMed
      7. Boero IJ, Gillespie EF, Hou J, Paravati AJ, Kim E, Einck JP, Yashar C, Mell L, Murphy JD. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2017 Mar 01; 97(3):571-580. PMID: 28126306.
        View in: PubMed
      8. Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, Bosch W, Straube W, Mell L, Moore KL. Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials. Int J Radiat Oncol Biol Phys. 2017 Jan 01; 97(1):164-172. PMID: 27979445.
        View in: PubMed
      9. Williamson CW, Green G, Noticewala SS, Li N, Shen H, Vaida F, Mell L. Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer. Int J Radiat Oncol Biol Phys. 2016 Nov 15; 96(4):801-807. PMID: 27788953.
        View in: PubMed
      10. Acevedo JR, Fero KE, Wilson B, Sacco AG, Mell L, Coffey CS, Murphy JD. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer. J Clin Oncol. 2016 Aug 22. PMID: 27551113.
        View in: PubMed
      11. Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD. Patterns of Palliative Care Consultation Among Elderly Patients With Cancer. J Natl Compr Canc Netw. 2016 Apr; 14(4):439-45. PMID: 27059192.
        View in: PubMed
      12. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell L. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. PMID: 26884579.
        View in: PubMed
      13. Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, Mell L, Thomas CR, Jabbour SK, Miller RC. Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. Am J Clin Oncol. 2016 Feb; 39(1):8-12. PMID: 24401669.
        View in: PubMed
      14. Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer J, Dale AM, Moiseenko V, Hattangadi-Gluth JA. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol. 2016 Jan; 118(1):29-34. PMID: 26806266; PMCID: PMC4764402 [Available on 01/21/17].
      15. Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell L, Le QT, Murphy JD. Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy. J Clin Oncol. 2016 Mar 01; 34(7):684-90. PMID: 26729432; PMCID: PMC4872027 [Available on 12/01/16].
      16. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell L, Parikh SA, Murphy JD. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):700-8. PMID: 26972642.
        View in: PubMed
      17. Wyss JC, Carmona R, Karunamuni RA, Pritz J, Hoh CK, Mell L. [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients. Radiother Oncol. 2016 Jan; 118(1):72-8. PMID: 26674924; PMCID: PMC4764473 [Available on 01/01/17].
      18. Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):297-304. PMID: 26853338; PMCID: PMC4747044 [Available on 02/01/17].
      19. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell L, Murphy JD. The impact of radiotherapy costs on clinical outcomes in breast cancer. Radiother Oncol. 2015 Nov; 117(2):393-9. PMID: 26472317; PMCID: PMC4758206 [Available on 11/01/16].
      20. Mell L. Cultivating Future Clinician Scientists: In Regard to Vapiwala et al. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):468. PMID: 26383687.
        View in: PubMed
      21. Paravati AJ, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell L, Murphy JD. Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer. J Oncol Pract. 2015 Sep; 11(5):403-9. PMID: 26265172; PMCID: PMC4575405.
      22. Mell L, Zakeri K. Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference? Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):732-4. PMID: 26104928.
        View in: PubMed
      23. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell L, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856. PMID: 26150579; PMCID: PMC4976490.
      24. Li Y, Hoisak JD, Li N, Jiang C, Tian Z, Gautier Q, Zarepisheh M, Wu Z, Liu Y, Jia X, Hattangadi-Gluth J, Mell L, Jiang S, Murphy JD. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Med Dosim. 2015; 40(4):318-24. PMID: 26002122.
        View in: PubMed
      25. Simpson DR, Scanderbeg DJ, Carmona R, McMurtrie RM, Einck J, Mell L, McHale MT, Saenz CC, Plaxe SC, Harrison T, Mundt AJ, Yashar CM. Clinical Outcomes of Computed Tomography-Based Volumetric Brachytherapy Planning for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):150-7. PMID: 26130230.
        View in: PubMed
      26. Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell L. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. PMID: 25857696.
        View in: PubMed
      27. Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell L. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy. J Med Imaging Radiat Oncol. 2015 Jun; 59(3):386-93; quiz 394. PMID: 25828068.
        View in: PubMed
      28. Graves YJ, Smith AA, Mcilvena D, Manilay Z, Lai YK, Rice R, Mell L, Jia X, Jiang SB, Cerviño L. A deformable head and neck phantom with in-vivo dosimetry for adaptive radiotherapy quality assurance. Med Phys. 2015 Apr; 42(4):1490-7. PMID: 25832039.
        View in: PubMed
      29. Zhen X, Chen H, Yan H, Zhou L, Mell L, Yashar CM, Jiang S, Jia X, Gu X, Cervino L. A segmentation and point-matching enhanced efficient deformable image registration method for dose accumulation between HDR CT images. Phys Med Biol. 2015 Apr 07; 60(7):2981-3002. PMID: 25790059.
        View in: PubMed
      30. Spiotto MT, Cao H, Mell L, Toback FG. Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer. Anticancer Drugs. 2015 Mar; 26(3):343-9. PMID: 25486599; PMCID: PMC4310759.
      31. Noticewala SS, Mell L, Olson SE, Read W. Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation. World J Clin Cases. 2015 Feb 16; 3(2):191-5. PMID: 25685767; PMCID: PMC4317614.
      32. Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell L, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015 Apr 15; 121(8):1303-11. PMID: 25537836; PMCID: PMC4774546.
      33. Simpson DR, Mell L, Cohen EE. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol. 2015 Apr; 51(4):291-8. PMID: 25532816.
        View in: PubMed
      34. Mell L, Zietman AL. Introducing prospective manuscript review to address publication bias. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):729-32. PMID: 25585776.
        View in: PubMed
      35. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell L, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. PMID: 25313184.
        View in: PubMed
      36. Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, Mell L, Murphy JD. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):224-30. PMID: 25195994; PMCID: PMC4187217.
      37. Carmona R, Gulaya S, Murphy JD, Rose BS, Wu J, Noticewala S, McHale MT, Yashar CM, Vaida F, Mell L. Validated competing event model for the stage I-II endometrial cancer population. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):888-98. PMID: 24969798.
        View in: PubMed
      38. Carmona R, Pritz J, Bydder M, Gulaya S, Zhu H, Williamson CW, Welch CS, Vaida F, Bydder G, Mell L. Fat composition changes in bone marrow during chemotherapy and radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Sep 01; 90(1):155-63. PMID: 25015207; PMCID: PMC4159416.
      39. Yeung HN, Mitchell WM, Roeland EJ, Xu B, Mell L, Le QT, Murphy JD. Palliative radiation before hospice: the long and the short of it. J Pain Symptom Manage. 2014 Dec; 48(6):1070-9. PMID: 24819083.
        View in: PubMed
      40. MacEwan IJ, Glembotski NE, D'Lima D, Bae W, Masuda K, Rashidi HH, Mell L, Bydder M. Proton density water fraction as a biomarker of bone marrow cellularity: validation in ex vivo spine specimens. Magn Reson Imaging. 2014 Nov; 32(9):1097-101. PMID: 25240720.
        View in: PubMed
      41. Mell L, Zakeri K, Rose BS. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. PMID: 24550413.
        View in: PubMed
      42. Li N, Zarepisheh M, Uribe-Sanchez A, Moore K, Tian Z, Zhen X, Graves YJ, Gautier Q, Mell L, Zhou L, Jia X, Jiang S. Automatic treatment plan re-optimization for adaptive radiotherapy guided with the initial plan DVHs. Phys Med Biol. 2013 Dec 21; 58(24):8725-38. PMID: 24301071.
        View in: PubMed
      43. Simpson DR, Martínez ME, Gupta S, Hattangadi-Gluth J, Mell L, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer. J Natl Cancer Inst. 2013 Dec 04; 105(23):1814-20. PMID: 24231453; PMCID: PMC4383284.
      44. Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell L. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014 Jan; 50(1):40-4. PMID: 24134948.
        View in: PubMed
      45. Mell L, Carmona R, Gulaya S, Lu T, Wu J, Saenz CC, Vaida F. Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study. J Natl Cancer Inst. 2013 Nov 06; 105(21):1656-66. PMID: 24123960.
        View in: PubMed
      46. Pan H, Rose BS, Simpson DR, Mell L, Mundt AJ, Lawson JD. Clinical practice patterns of lung stereotactic body radiation therapy in the United States: a secondary analysis. Am J Clin Oncol. 2013 Jun; 36(3):269-72. PMID: 22495454; PMCID: PMC3396796.
      47. Murphy JD, Nelson LM, Chang DT, Mell L, Le QT. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract. 2013 Sep; 9(5):e220-7. PMID: 23943892.
        View in: PubMed
      48. Liang Y, Kim GY, Pawlicki T, Mundt AJ, Mell L. Feasibility study on dosimetry verification of volumetric-modulated arc therapy-based total marrow irradiation. J Appl Clin Med Phys. 2013 Mar 04; 14(2):3852. PMID: 23470926.
        View in: PubMed
      49. Gu X, Dong B, Wang J, Yordy J, Mell L, Jia X, Jiang SB. A contour-guided deformable image registration algorithm for adaptive radiotherapy. Phys Med Biol. 2013 Mar 21; 58(6):1889-901. PMID: 23442596.
        View in: PubMed
      50. Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, Yashar CM, Mundt AJ, Mell L. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013 Jan; 23(1):119-25. PMID: 23262521.
        View in: PubMed
      51. Mell L. Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesis. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):566-8. PMID: 22999264.
        View in: PubMed
      52. Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell L. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. PMID: 23063467; PMCID: PMC3525784.
      53. Park JC, Park SH, Kim JH, Yoon SM, Song SY, Liu Z, Song B, Kauweloa K, Webster MJ, Sandhu A, Mell L, Jiang SB, Mundt AJ, Song WY. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys. 2012 Oct; 39(10):6431-42. PMID: 23039678.
        View in: PubMed
      54. Song S, Rudra S, Hasselle MD, Dorn PL, Mell L, Mundt AJ, Yamada SD, Lee NK, Hasan Y. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer. 2013 Jan 15; 119(2):325-31. PMID: 22806897.
        View in: PubMed
      55. Liang Y, Bydder M, Yashar CM, Rose BS, Cornell M, Hoh CK, Lawson JD, Einck J, Saenz C, Fanta P, Mundt AJ, Bydder GM, Mell L. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):406-14. PMID: 22687195.
        View in: PubMed
      56. Mell L, Lau SK, Rose BS, Jeong JH. Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review. Contemp Clin Trials. 2012 Sep; 33(5):920-4. PMID: 22664646.
        View in: PubMed
      57. Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell L. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. PMID: 22516388.
        View in: PubMed
      58. Khan A, Jensen LG, Sun S, Song WY, Yashar CM, Mundt AJ, Zhang FQ, Jiang SB, Mell L. Optimized planning target volume for intact cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1500-5. PMID: 22270167.
        View in: PubMed
      59. Rose BS, Liang Y, Lau SK, Jensen LG, Yashar CM, Hoh CK, Mell L. Correlation between radiation dose to ¹8F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1185-91. PMID: 22270171.
        View in: PubMed
      60. Rose BS, Jeong JH, Nath SK, Lu SM, Mell L. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011 Sep 10; 29(26):3503-9. PMID: 21844503.
        View in: PubMed
      61. Moiseenko V, Song WY, Mell L, Bhandare N. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol. 2011 Jun 06; 6:61. PMID: 21645390; PMCID: PMC3127783.
      62. Devisetty K, Wong SJ, Mell L. How does TPF improve survival over PF? Lancet Oncol. 2011 May; 12(5):419-20; author reply 421-2. PMID: 21536218.
        View in: PubMed
      63. Pan H, Simpson DR, Mell L, Mundt AJ, Lawson JD. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011 Oct 01; 117(19):4566-72. PMID: 21412761; PMCID: PMC3142290.
      64. Tyagi N, Lewis JH, Yashar CM, Vo D, Jiang SB, Mundt AJ, Mell L. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):273-80. PMID: 21109360.
        View in: PubMed
      65. Mell L, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Predictors of competing mortality in early breast cancer. Cancer. 2010 Dec 01; 116(23):5365-73. PMID: 20737562.
        View in: PubMed
      66. Mell L, Jeong JH. Pitfalls of using composite primary end points in the presence of competing risks. J Clin Oncol. 2010 Oct 01; 28(28):4297-9. PMID: 20713860.
        View in: PubMed
      67. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell L. A survey of image-guided radiation therapy use in the United States. Cancer. 2010 Aug 15; 116(16):3953-60. PMID: 20564090; PMCID: PMC2919592.
      68. Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell L. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010 Aug 15; 11(4):3255. PMID: 21081882.
        View in: PubMed
      69. Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, Hasan Y, Roeske JC, Mundt AJ, Mell L. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1436-45. PMID: 20708346.
        View in: PubMed
      70. Lim K, Small W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell L, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):348-55. PMID: 20472347.
        View in: PubMed
      71. Liang Y, Messer K, Rose BS, Lewis JH, Jiang SB, Yashar CM, Mundt AJ, Mell L. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):912-9. PMID: 20472344; PMCID: PMC2923677.
      72. Nichols MA, Mell L, Hasselle MD, Karrison TG, MacDermed D, Meriwether A, Witt ME, Weichselbaum RR, Chmura SJ. Outcomes in black patients with early breast cancer treated with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):392-9. PMID: 20434849.
        View in: PubMed
      73. Rose BS, Aydogan B, Liang Y, Yeginer M, Hasselle MD, Dandekar V, Bafana R, Yashar CM, Mundt AJ, Roeske JC, Mell L. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7. PMID: 20400238; PMCID: PMC2907446.
      74. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell L. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol. 2009 Dec; 6(12):876-83. PMID: 19945044.
        View in: PubMed
      75. Mell L, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol. 2010 Jan 01; 28(1):15-20. PMID: 19933920.
        View in: PubMed
      76. Devisetty K, Mell L, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009 Nov; 93(2):298-301. PMID: 19717198.
        View in: PubMed
      77. Al-Hallaq HA, Mell L, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, Newstead GM, Chmura SJ. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008 Nov 01; 113(9):2408-14. PMID: 18823018.
        View in: PubMed
      78. Mell L, Movsas B. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine. Expert Opin Drug Metab Toxicol. 2008 Oct; 4(10):1341-50. PMID: 18798703.
        View in: PubMed
      79. Salama JK, Stenson KM, List MA, Mell L, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008 Oct; 134(10):1060-5. PMID: 18936351.
        View in: PubMed
      80. Mell L, Tiryaki H, Ahn KH, Mundt AJ, Roeske JC, Aydogan B. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1504-10. PMID: 18640499.
        View in: PubMed
      81. Mell L, Mundt AJ. Intensity-modulated radiation therapy in gynecologic cancers: growing support, growing acceptance. Cancer J. 2008 May-Jun; 14(3):198-9. PMID: 18536560.
        View in: PubMed
      82. Small W, Mell L, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):428-34. PMID: 18037584; PMCID: PMC2752724.
      83. Mell L, Weichselbaum RR. More on cetuximab in head and neck cancer. N Engl J Med. 2007 Nov 22; 357(21):2201-2; author reply 2202-3. PMID: 18032774.
        View in: PubMed
      84. Mell L, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Apr 01; 70(5):1431-7. PMID: 17996390.
        View in: PubMed
      85. Salama JK, Mell L, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007 Oct 10; 25(29):4581-6. PMID: 17925552.
        View in: PubMed
      86. Mell L, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):111-8. PMID: 17289291.
        View in: PubMed
      87. Mell L, Kochanski JD, Roeske JC, Haslam JJ, Mehta N, Yamada SD, Hurteau JA, Collins YC, Lengyel E, Mundt AJ. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1356-65. PMID: 16757127.
        View in: PubMed
      88. Kochanski JD, Mell L, Roeske JC, Mundt AJ. Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions. Clin Adv Hematol Oncol. 2006 May; 4(5):379-86. PMID: 16728946.
        View in: PubMed
      89. Aydogan B, Mundt AJ, Smith BD, Mell L, Wang S, Sutton H, Roeske JC. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):266-73. PMID: 16618581.
        View in: PubMed
      90. Mell L, Mundt AJ. Radiation therapy in the elderly. Cancer J. 2005 Nov-Dec; 11(6):495-505. PMID: 16393484.
        View in: PubMed
      91. Mell L, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005 Sep 15; 104(6):1296-303. PMID: 16078260.
        View in: PubMed
      92. Mell L, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics. 2005 Jul; 116(1):56-60. PMID: 15995031.
        View in: PubMed
      93. Schroder M, Mell L, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W, Mundt AJ. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):1078-86. PMID: 15752887.
        View in: PubMed
      94. Mell L, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT. Compliance with national immunization guidelines for children younger than 2 years, 1996-1999. Pediatrics. 2005 Feb; 115(2):461-7. PMID: 15687456.
        View in: PubMed
      95. Mell L, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD, Montag AG, Mundt AJ. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Cancer Res. 2004 Aug 15; 10(16):5546-53. PMID: 15328195.
        View in: PubMed
      96. Schomas DA, Milano MT, Roeske JC, Mell L, Mundt AJ. Intensity-modulated radiotherapy and the Internet. Cancer. 2004 Jul 15; 101(2):412-20. PMID: 15241841.
        View in: PubMed
      97. Roeske JC, Bonta D, Mell L, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol. 2003 Nov; 69(2):201-7. PMID: 14643959.
        View in: PubMed
      98. Mundt AJ, Mell L, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Aug 01; 56(5):1354-60. PMID: 12873680.
        View in: PubMed
      99. Mell L, Mundt AJ. Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?". Gynecol Oncol. 2003 Aug; 90(2):499; author reply 499-500. PMID: 12893236.
        View in: PubMed
      100. Mell L, Roeske JC, Mundt AJ. A survey of intensity-modulated radiation therapy use in the United States. Cancer. 2003 Jul 01; 98(1):204-11. PMID: 12833473.
        View in: PubMed
      101. Mell L, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics. 2003 Feb; 111(2):296-301. PMID: 12563054.
        View in: PubMed